Amplicon details |
||
Amplicon: |
173 bp | |
1 ggatctcctg tcatctcacc ttgctcctgc cgagaaagta tccatcatgg 51 ctgatgcaat gcggcggctg catacgcttg atccggctac ctgcccattc 101 gaccaccaag cgaaacatcg catcgagcga gcacgtactc ggatggaagc 151 cggtcttgtc gatcaggatg atc |
Record ID | Database | Record description | Record length | Taxon | Method | Amplicon size | Match details |
---|---|---|---|---|---|---|---|
OF125925.1 | emblrelpat | KR 1020200126439-A/76: HUMANIZED NO... | 185159 bp | synthetic construct | QL-ELE-00-003 | 173 bp | View |
OF129903.1 | emblrelpat | KR 1020200133827-A/14: EXPRESSION V... | 795 bp | synthetic construct | QL-ELE-00-003 | 173 bp | View |
OF129904.1 | emblrelpat | KR 1020200133827-A/15: EXPRESSION V... | 1677 bp | synthetic construct | QL-ELE-00-003 | 173 bp | View |
OF133035.1 | emblrelpat | KR 1020200140934-A/9: NON-HUMAN ANI... | 17210 bp | synthetic construct | QL-ELE-00-003 | 173 bp | View |
OF133038.1 | emblrelpat | KR 1020200144576-A/5: TREATMENT OF ... | 3756 bp | synthetic construct | QL-ELE-00-003 | 173 bp | View |
OF133199.1 | emblrelpat | KR 1020200146046-A/51: Cells Useful... | 7570 bp | synthetic construct | QL-ELE-00-003 | 173 bp | View |
OF133200.1 | emblrelpat | KR 1020200146046-A/53: Cells Useful... | 6259 bp | synthetic construct | QL-ELE-00-003 | 173 bp | View |
OF300344.1 | emblrelpat | KR 1020210100585-A/73: MARKER COMPO... | 4560 bp | synthetic construct | QL-ELE-00-003 | 173 bp | View |
OF338415.1 | emblrelpat | KR 1020210126680-A/145: COMPOSITION... | 933 bp | synthetic construct | QL-ELE-00-003 | 173 bp | View |
OF352222.1 | emblrelpat | KR 1020210148182-A/1: ENGINEERED DY... | 3581 bp | synthetic construct | QL-ELE-00-003 | 173 bp | View |
OF355301.1 | emblrelpat | KR 1020210145221-A/856: IMMUNOGENIC... | 10892 bp | synthetic construct | QL-ELE-00-003 | 173 bp | View |
OG163468.1 | emblrelpat | WO 2020262150-A/1: Lipid nanoparticles. | 7037 bp | synthetic construct | QL-ELE-00-003 | 173 bp | View |
OG165934.1 | emblrelpat | WO 2021015297-A/28: Transgenic non-... | 3428 bp | synthetic construct | QL-ELE-00-003 | 173 bp | View |
OG165935.1 | emblrelpat | WO 2021015297-A/29: Transgenic non-... | 3489 bp | synthetic construct | QL-ELE-00-003 | 173 bp | View |
OG165936.1 | emblrelpat | WO 2021015297-A/30: Transgenic non-... | 3467 bp | synthetic construct | QL-ELE-00-003 | 173 bp | View |
PA261417.1 | emblrelpat | JP 2021061809-A/1: pHluorin-Sema 3A... | 18685 bp | synthetic construct | QL-ELE-00-003 | 173 bp | View |
PA263415.1 | emblrelpat | JP 2021078362-A/4: Method for intro... | 11588 bp | synthetic construct | QL-ELE-00-003 | 173 bp | View |
PA264904.1 | emblrelpat | WO 2021095802-A/4: Method for intro... | 11588 bp | synthetic construct | QL-ELE-00-003 | 173 bp | View |
PA270262.1 | emblrelpat | WO 2021132638-A/88: IL-36R SIGNAL-S... | 5145 bp | synthetic construct | QL-ELE-00-003 | 173 bp | View |
PA272107.1 | emblrelpat | JP 2021511831-A/8: MESENCHYMAL STEM... | 795 bp | synthetic construct | QL-ELE-00-003 | 173 bp | View |
Related publications:
Petrillo, M., et al. “JRC GMO-Amplicons: A Collection of Nucleic Acid Sequences Related to Genetically Modified Organisms.” Database (Oxford), vol. 2015 bav101, 30 Sep. 2015, doi:10.1093/database/bav101.
Angers-Loustau, A., et al. “Using the EURL GMFF Online Bioinformatics Resources: A how-to Guide for Practical JRC GMO-Matrix and JRC GMO-Amplicons Case Uses.” European Commission, Ispra, JRC101853, 2016.